Large-scale testing (Phase 3)Ended earlyNCT00549757
What this trial is testing
Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases)
Who this might be right for
Type 2 Diabetes MellitusCardiovascular Disease
Novartis Pharmaceuticals 8,606